Second primary malignancy risk after radiotherapy in rectal cancer survivors.
CONCLUSION: In this large population-based cohort study, we demonstrated that radiotherapy had no increase in SPM.
PMID: 30386108 [PubMed - in process]
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW Tags: World J Gastroenterol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Gastroenterology | Health Insurance | Insurance | Liver | Rectal Cancers | Study | Taiwan Health | Urology & Nephrology